These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 14767435)

  • 1. Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response.
    Tulic MK; Fiset PO; Christodoulopoulos P; Vaillancourt P; Desrosiers M; Lavigne F; Eiden J; Hamid Q
    J Allergy Clin Immunol; 2004 Feb; 113(2):235-41. PubMed ID: 14767435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy increases CD4+CD25+ T cells in the nasal mucosa of subjects with allergic rhinitis.
    Asai K; Foley SC; Sumi Y; Yamauchi Y; Takeda N; Desrosiers M; Lavigne F; Hamid Q
    Allergol Int; 2008 Dec; 57(4):377-81. PubMed ID: 18797179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local induction of a specific Th1 immune response by allergen linked immunostimulatory DNA in the nasal explants of ragweed-allergic subjects.
    Tulic MK; Christodoulopoulos P; Fiset PO; Vaillancourt P; Lavigne F; Marshall JD; Van Nest G; Eiden JJ; Hamid Q
    Allergol Int; 2009 Dec; 58(4):565-72. PubMed ID: 19776676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective immune redirection in humans with ragweed allergy by injecting Amb a 1 linked to immunostimulatory DNA.
    Simons FE; Shikishima Y; Van Nest G; Eiden JJ; HayGlass KT
    J Allergy Clin Immunol; 2004 Jun; 113(6):1144-51. PubMed ID: 15208597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis.
    Creticos PS; Schroeder JT; Hamilton RG; Balcer-Whaley SL; Khattignavong AP; Lindblad R; Li H; Coffman R; Seyfert V; Eiden JJ; Broide D;
    N Engl J Med; 2006 Oct; 355(14):1445-55. PubMed ID: 17021320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sublingual immunotherapy in patients with allergic rhinoconjunctivitis caused by ragweed pollen.
    Skoner D; Gentile D; Bush R; Fasano MB; McLaughlin A; Esch RE
    J Allergy Clin Immunol; 2010 Mar; 125(3):660-6, 666.e1-666.e4. PubMed ID: 20153030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Grass pollen immunotherapy: symptomatic improvement correlates with reductions in eosinophils and IL-5 mRNA expression in the nasal mucosa during the pollen season.
    Wilson DR; Nouri-Aria KT; Walker SM; Pajno GB; O'Brien F; Jacobson MR; Mackay IS; Durham SR
    J Allergy Clin Immunol; 2001 Jun; 107(6):971-6. PubMed ID: 11398073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allergen-specific T cell responses to immunotherapy monitored by CD154 and intracellular cytokine expression.
    Campbell JD; Buchmann P; Kesting S; Cunningham CR; Coffman RL; Hessel EM
    Clin Exp Allergy; 2010 Jul; 40(7):1025-35. PubMed ID: 20412135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of oral immunotherapy with short ragweed extract.
    Van Deusen MA; Angelini BL; Cordoro KM; Seiler BA; Wood L; Skoner DP
    Ann Allergy Asthma Immunol; 1997 Jun; 78(6):573-80. PubMed ID: 9207721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nasal immunotherapy in weed-induced allergic rhinitis.
    Gaglani B; Borish L; Bartelson BL; Buchmeier A; Keller L; Nelson HS
    Ann Allergy Asthma Immunol; 1997 Sep; 79(3):259-65. PubMed ID: 9305235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of subcutaneous immunotherapy with a biologically standardized extract of Ambrosia artemisiifolia pollen: a double-blind, placebo-controlled study.
    Mirone C; Albert F; Tosi A; Mocchetti F; Mosca S; Giorgino M; Pecora S; Parmiani S; Ortolani C
    Clin Exp Allergy; 2004 Sep; 34(9):1408-14. PubMed ID: 15347374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoreactivity profile of peripheral blood mononuclear cells from patients with ragweed-induced allergic rhinitis.
    Sun J; Wong B; Cundall M; Goncharova S; Conway M; Dalrymple A; Coyle AJ; Waserman S; Jordana M
    Clin Exp Allergy; 2007 Jun; 37(6):901-8. PubMed ID: 17517104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cry j 1-induced synthesis of interleukin-5 and interferon-gamma by peripheral blood mononuclear cells of patients with seasonal allergic rhinitis due to Japanese cedar pollens.
    Nakai Y; Ohashi Y; Tanaka A; Kakinoki Y; Washio Y; Masamoto T; Yamada K; Nakai Y; Ohmoto Y
    Acta Otolaryngol Suppl; 1998; 538():143-51. PubMed ID: 9879414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluticasone propionate aqueous nasal spray reduces inflammatory cells in unchallenged allergic nasal mucosa: effects of single allergen challenge.
    Holm A; Dijkstra M; Kleinjan A; Severijnen LA; Boks S; Mulder P; Fokkens W
    J Allergy Clin Immunol; 2001 Apr; 107(4):627-33. PubMed ID: 11295650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined diesel exhaust particulate and ragweed allergen challenge markedly enhances human in vivo nasal ragweed-specific IgE and skews cytokine production to a T helper cell 2-type pattern.
    Diaz-Sanchez D; Tsien A; Fleming J; Saxon A
    J Immunol; 1997 Mar; 158(5):2406-13. PubMed ID: 9036991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in upper airway diseases and allergen immunotherapy.
    Nelson HS
    J Allergy Clin Immunol; 2007 Apr; 119(4):872-80. PubMed ID: 17292953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conjugation of immunostimulatory DNA to the short ragweed allergen amb a 1 enhances its immunogenicity and reduces its allergenicity.
    Tighe H; Takabayashi K; Schwartz D; Van Nest G; Tuck S; Eiden JJ; Kagey-Sobotka A; Creticos PS; Lichtenstein LM; Spiegelberg HL; Raz E
    J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 1):124-34. PubMed ID: 10887315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults.
    Creticos PS; Maloney J; Bernstein DI; Casale T; Kaur A; Fisher R; Liu N; Murphy K; Nékám K; Nolte H
    J Allergy Clin Immunol; 2013 May; 131(5):1342-9.e6. PubMed ID: 23622121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of nasal immunohistology in patients with seasonal rhinoconjunctivitis treated with topical steroids or specific allergen immunotherapy.
    Rak S; Heinrich C; Scheynius A
    Allergy; 2005 May; 60(5):643-9. PubMed ID: 15813810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-9 and c-Kit+ mast cells in allergic rhinitis during seasonal allergen exposure: effect of immunotherapy.
    Nouri-Aria KT; Pilette C; Jacobson MR; Watanabe H; Durham SR
    J Allergy Clin Immunol; 2005 Jul; 116(1):73-9. PubMed ID: 15990777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.